Antibody Response to Omicron BA.4-BA.5 Bivalent Booster
- PMID: 36630643
- PMCID: PMC9847504
- DOI: 10.1056/NEJMc2213907
Antibody Response to Omicron BA.4-BA.5 Bivalent Booster
Figures
References
-
- Food and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes Moderna, Pfizer-BioNTech bivalent COVID-19 vaccines for use as a booster dose. August 31, 2022. (https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19...).
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical